NEW YORK (GenomeWeb) – Human Longevity announced on Tuesday that it has received CLIA certification for its laboratory.
Californiagranted the firm its CLIA license under the "deemed status" provision of the Centers for Medicare and Medicaid Services, Human Longevity said.
In a statement Human Longevity CEO and Co-founder Craig Venter called the achievement an "important regulatory milestone" for the firm.
San Diego-based Human Longevity is building a database of human genotypes and phenotypes. It is looking to integrate whole genome sequence data with clinical measures and imaging in its Knowledgebase informatics platform, the firm said in a statement.
In January, the firm signed a partnership with Personal Genome Diagnostics to get access to PGDx cancer panels including CancerSelect, PlasmaSelect, CancerXome, METDetec, and CancerComplete. It also licensed the PGDx Enterprise Solution platform.
In recent months, the firm has been racking up partnerships to sequence patient samples from firms such as Genentech and organizations such as the Twins UK Registry.